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SUMMARY
In this systematic review, walking (a generally accessible activity for a largely sedentary population),
was assessed as a preventive risk factor for development of fatal and nonfatal cardiovascular disease
(CVD). PubMed, CINHAL, and reference list searches identified 21 peer reviewed publications
examining walking in relation to CVD; studies assessing active transportation were excluded.
Generally, there were dose-dependent reductions in CVD risk with higher walking duration, distance,
energy expenditure, and pace. Associations appeared to be stronger for ischemic stroke than other
CVD outcomes such as CHD or hemorrhagic stroke. Adjustment for clinical CVD risk factors,
obesity, or other types of physical activity generally attenuated but did not eliminate associations.
Because functional status may be an important determinant of walking behavior in adults, potential
bias due to pre-existing illness is of concern in all studies reviewed, particularly in case-control studies
which ascertain walking retrospectively and yielded the strongest associations. Study findings were
consistent with current physical activity recommendations, but opportunities for future research
include improvements in measurement of walking and other CVD risk factors, more thorough control
for pre-existing illness, examination of mediating or moderating conditions such as obesity, and other
analytical issues.
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INTRODUCTION
Physical activity (PA) recommendations from the American College of Sports Medicine and
American Heart Association (AHA) include moderate intensity PA (MPA) for prevention of
chronic conditions such as obesity (1–3) and cardiovascular disease (CVD), major contributors
to mortality and morbidity in the United States (4) and globally (5). While overall PA is a well
established determinant of numerous health outcomes (3,4), the health benefits of MPA (3)
remain unclear (6,7). Walking is the most common PA among adults (8,9) and an accessible
form of MPA particularly relevant for the obese, who are less likely to perform vigorous PA
(VPA) (10). Therefore, understanding the relationship between walking and CVD is especially
valuable.
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A recent meta-analysis found dose-dependent, negative associations of walking with CVD and
all-cause mortality (11). While promising, pooled results do not address variability in findings
which may result from methodological differences among studies or mechanistic differences
among CVD outcomes. Study results may be sensitive to adjustment for other types of PA or
clinical CVD risk factors such as body weight, blood pressure or serum lipid levels (12,13).
Additionally, the numerous coronary and stroke outcomes encompassed by CVD have shared
and independent etiologies (4), so walking may affect specific CVD diseases or conditions
differently.
Examination of these complexities can improve understanding of the causal relationship
between walking and CVD, the mediating role of other CVD determinants, and etiological
differences between CVD outcomes, as well as identify methodological improvements for
future work. Existing literature reviews assessing walking effects on CVD do not address these
issues or are non-systematic (14,15). We conducted a systematic review with the following
objectives: (a) to compare and synthesize existing observational evidence of the relationship
between walking and CVD risk, (b) to explore discrepant findings with regard to variations in
study design and analysis, and (c) to make recommendations for future study.
METHODS
Search Criteria
Because research on the health effects of walking was scant prior to 1995, when MPA was
added to PA recommendations (2,16), we conservatively included studies that examined the
association between walking and CVD and were published several years prior (January 1, 1990)
through July 31, 2007. Consistent with the AHA CVD definition (4,17), our search included
terms related to coronary heart disease (CHD) and stroke.
We defined walking as total or leisure walking and excluded studies that examined walking in
combination with cycling (e.g., (18,19)) or walking for transportation (e.g., (20–22)) because
it was usually combined with cycling. Cycling can be performed at high intensities (23), is
more strongly related to other types of PA (24), and likely contributes to combined measures
(walking and cycling) differentially across gender (24) and countries (25).
Search criteria were developed and validated against a known set of relevant publications, then
applied to two databases: (a) PubMed was searched for “walking” and “coronary
arteriosclerosis,” “cardiovascular diseases,” “cerebrovascular accident”, or “cardiovascular
surgical procedures” in Medical Subject Heading (MeSH) or text fields. Additional CVD terms
were included in the text search. The PubMed search targeted observational studies by
including terms such as prevention and control, epidemiology, primary prevention, or risk
factors. To include observational arms of clinical trials, publication type was not used to filter
clinical trials. (b) The Cumulated Index to Nursing and Allied Health Literature (CINHAL)
was searched using parallel terms within main headings and abstract text. Publications with
“rehabilitation” or “diagnosis” in the subject heading were excluded.
A primary reviewer screened publications using six inclusion criteria: (a) study population of
healthy human adults, (b) walking as exposure, (c) fatal or nonfatal CVD as outcome, (d)
observational cohort or case-control design, (e) publication in English, and (f) peer reviewed.
Studies assessing walking for secondary prevention among CVD patients were excluded (e.g.,
(26,27)). Intervention studies were excluded due to short term follow-up and distinct limitations
and biases. Cross-sectional studies were excluded given the quantity of longitudinal studies on
this topic. Case-control designs were included because they are commonly used to study acute
conditions such as myocardial infarction and stroke. Non-peer reviewed studies were excluded
because they could not be systematically searched and have not been appraised through peer
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review. One study meeting inclusion criteria was excluded because only age-adjusted rates
were reported (28), reducing comparability to other studies.
Publications were screened first by title; if the title was ambiguous with regard to inclusion
criteria, the abstract and/or full article was retrieved and reviewed. To supplement the literature
database searches, we conducted a manual search designed to capture references missing due
to subject terms employed by the database provider, author, or publisher. Reference lists of
included studies and related review articles were scanned using the same protocol; potential
publications were screened according to the same inclusion criteria.
Data abstraction and synthesis
A priori data elements were extracted by the primary reviewer. One of three secondary
reviewers verified the extracted information. Disagreements were resolved discursively.
Some effect estimates were converted to reflect walking associations relative to the lowest
walking category: the effect (risk ratio (RR), hazard ratio (HR), or odds ratio (OR)) for each
category was divided by the effect for the lowest walking category. To illustrate the overall
dose-response relationship, walking measures were converted into Metabolic Equivalent
(MET)-hours/week assuming 3 MET intensity (2.5 mph (23)) and, for conversion of
kilocalories, 150 pound body weight (approximately the average weight of U.S. females
(29)). The midpoint of each MET-hours/week category was plotted against the reported or
converted, fully adjusted effect estimate; when the upper limit of the largest walking category
was unreported, it was assigned as twice the value of the lower limit. Converted estimates were
used for interpretation and in the dose-response figure but not included in the tables presented.
We report “minimal adjustment” and “full adjustment” results when available. Generally,
minimal adjustment included age and basic characteristics such as race or study center, and
full adjustment included various combinations of socioeconomic measures, other health-
related behaviors, or parental history of CVD. We specifically report adjustment for key
variables of interest: other PA, diet, clinical CVD risk factors (e.g., blood lipids, blood pressure,
body mass index (BMI)), and pre-existing conditions.
Assessment of validity and test-retest reliability of the walking assessment tools referenced in
the reviewed articles were extracted. Walking was generally one component of total PA
assessment, so we distinguish between measurement properties of the overall PA assessment
instrument versus walking measure.
Studies were grouped by and compared within comparable walking measures (frequency,
duration, distance, or pace). Results are separated by case-control versus cohort design because
of distinct biases inherent to each design.
RESULTS
The PubMed search returned 507 publications; of these, 96 abstracts or papers were considered
for full review and 19 met all eligibility criteria. The CINHAL search returned 487 publications;
of these, 10 abstracts or papers not already reviewed were considered for full review, and none
met all eligibility criteria. Reference list searches identified 2 additional papers for inclusion,
for a total of 21 studies included in this systematic review.
Walking measures were self-reported and represented walking frequency, duration (Table 1),
distance (Table 2), energy expenditure (Table 3), or pace (Table 4). Case-control studies are
presented in Table 5. While distance and energy expenditure are determined in part by walking
pace, they were generally ascertained independently of walking pace. Therefore, we interpreted
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walking pace as intensity, and remaining measures as “volume.” Walking exposures were often
secondary to general measures of PA. Study outcomes included fatal and nonfatal CHD, total
CVD, other CVD (primarily stroke), stroke (total, ischemic, or hemorrhagic), and myocardial
infarction (MI).
Overall Findings
Reviewed studies suggest that walking is associated with lower CVD risk in apparently healthy
adults (Table 1–Table 5). Fully adjusted HR’s, RR’s, or OR’s for walking volume ranged from
0.4 to 1.3 for CHD, 0.4 to 0.9 for total CVD, 0.4 to 1.0 for ischemic stroke, and 0.5 to 1.3 for
hemorrhagic stroke.
Four issues emerged: 1) dose-response of CVD risk with walking volume and pace; the strength
of association varying by 2) study design (case-control or cohort) and 3) study outcome; and
4) analytical issues such as inclusion of clinical CVD risk factors or other PA.
Dose-response
Frequency—Two studies examined frequency, showing non-significant, negative
associations with ischemic stroke and CHD (Table 1) (30,31). Frequency was dichotomized
as walking often versus not often, so dose-response was not evaluated.
Duration—In general, there were significant, negative dose-response relationships between
weekly walking duration and CVD and CHD (Table 1). In Women’s Health Study participants
with no VPA, CHD risk was reduced by 14%, 51%, and 52% in those reporting 1–59 minutes,
1–1.5 hours, and >2 hours/week of walking, respectively, compared to no regular walking
(32). Similar patterns were reported in other studies (33,34).
Distance—Similarly, longer walking distance per week or day was generally associated with
incremental reductions in CVD risk (Table 2). In the 2–4 year follow-up of men in the Honolulu
Heart Program, statistically significant 9% and 57% reductions (converted from RR=1.1 and
2.3) in fatal or nonfatal CHD were observed for those walking 0.25–1.5 and >1.5 miles/day,
respectively, versus >0–<0.25 miles/day (35). Reductions in CHD or stroke mortality among
a smaller group of men from the same study population followed over 12 years were similar
but not significant (36). Smith et al. reported a non-significant increase in CHD mortality with
increasing walking, but a dose-dependent reduction in other CVD mortality for men with longer
distance walked (37). Among men in the Harvard Alumni Study, reduction in stroke risk was
observed for the highest walking level (38) while reductions in CHD risk (39) plateaued with
greater distance walked. For women in the College Alumni Health Study, reductions in CVD
risk with greater walking distance were not statistically significant (40).
Energy expenditure from walking—Several studies reported dose-dependent reductions
in CVD risk with higher energy expenditure from walking (Table 3) (41–43). For example,
among women in the Nurses Health Study who reported no VPA, fully adjusted RR’s for fatal
and non-fatal coronary events were 0.78, 0.88, 0.70, and 0.65 for increasing walking MET-
hour quintiles (43). However, while women in the Study of Osteoporotic Fractures reporting
187–419 versus <70 kcal/week from walking experienced significant, 34% reductions in CVD
mortality, reductions were similar for higher levels of walking (44). Men in the Health
Professionals Follow-Up Study with <1 hour/week VPA exhibited an inconsistent dose-
response relationship between CHD risk and MET-hours of walking, reaching a small but
significant 18% reduction for 14.75 MET-hours of walking/week (approximately 30 minutes/
day) compared to those with <1.2 MET-hours/week (45).
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An illustration of the dose-response relationship between walking measures (converted into
MET-hours/week) and total CVD, CHD, and stroke across studies (Figure 1) shows a generally
consistent decrease in CVD risk, with some evidence of a saturation effect with the highest
levels of walking.
Pace: Dose-dependent associations between walking pace and CVD were particularly strong
(Table 4). In the Health Professionals Follow-Up Study, men reporting walking paces of 2–3,
3–4, and >4 mph experienced significant 26%, 40%, and 50% fully adjusted reductions in risk
of fatal and non-fatal CHD compared to <2 mph (45), with little change after adjusting for
energy expenditure from walking. Men in the Whitehall Study exhibited similar associations
for CHD mortality and stronger associations for other CVD deaths (46). Women’s Health
Initiative Observational Study participants reporting walking paces of 2–3, 3–4, and >4 mph
experienced a significant negative trend (14%, 24%, and 42% fully adjusted reductions,
respectively) in CVD incidence compared to those who rarely or never walk (42). Women in
the Nurses Health Study had similar reductions in risk for coronary events (43) and stronger
reductions in total stroke (19% and 51% for 2–2.9 mph and ≥3 mph versus <2 mph,
respectively) (41). Women’s Health Study participants reporting walking paces of <3.2, 3.2–
4.7, and ≥4.8 km/hour (<2, 2–2.9, ≥3 mph) had reductions of 44%, 29%, and 48% in CHD
risk, respectively, compared to irregular walkers (32).
Study Design
The majority of studies were prospective, but case-control designs (Table 5) were common for
MI and stroke outcomes and yielded the strongest associations. For example, in a case-control
study in the United Kingdom, men and women reporting ≥1 mile (versus <1 mile) walking/
day had a 68% reduction in non-fatal stroke odds (47). In contrast, in a cohort study of over
14,000 men and women, those walking very often or often (versus not often) had a non-
significant, 13% reduction in ischemic stroke despite generally stronger associations for
ischemic versus total stroke in other studies (Table 1) (30).
Study Outcome
The patterning of associations by study design makes it difficult to distinguish influences of
study design versus outcome on estimated effects. In a case-control study of nonfatal MI, fully
adjusted OR’s ranged from 0.31 to 0.38 for walking an average of 112 to 1,111, compared to
0 kilocalories/week from among those reporting no strenuous PA (Table 5) (48). Strong
associations between primary cardiac arrest and weekly walking duration (adjusted OR=0.27)
were reported in a similar case-control study (Table 5) (49). In contrast, in the Women’s Health
Initiative Observational Study, a large, prospective cohort study, fully adjusted RR’s for total
CVD ranged from 0.68 to 0.91 for comparable energy expenditure categories (Table 3) (42);
estimates were consistent with the majority of cohort studies reviewed. On the other hand,
another case-control study reported a moderate, 23% reduction in nonfatal MI odds with daily
walking (converted from OR=1.3; Table 5) (50).
Among cohort studies, walking-CVD associations are more consistent for total CVD and
ischemic stroke than CHD or hemorrhagic stroke (Figure 1). Studies examining multiple
outcomes generally suggested stronger associations with ischemic stroke than CHD or total
CVD. Noda et al. found incremental reductions in fully adjusted hazard estimates with
increased walking duration in a large cohort of Japanese men and women, reaching 0.56 for
ischemic stroke and 0.74 for CHD, but only results for ischemic stroke were statistically
significant (Table 1) (33). Men in the Harvard Alumni Study reporting ≥20 km/week (≥1.8 mi/
day) versus <5 km/week (<0.45 mi/day) experienced risk reductions of 29% for total stroke
(38) and approximately 10% for CHD (39) (Table 2). In contrast, in the Atherosclerosis Risk
in Communities Study, frequent walking was associated with 25% and 38% reductions in fatal
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and nonfatal CHD risk in men and women, respectively (31), and a 13% reduction in ischemic
stroke (30), although these associations were not statistically significant (Table 1).
Hu et al. reported stronger associations for ischemic versus hemorrhagic stroke in the Nurses
Health Study: fully adjusted HR’s comparing ≥10 versus ≤0.5 MET-hours per week of walking
were 0.60 and 1.02 for ischemic and hemorrhagic stroke, respectively. However, statistical
power was limited by the small number of hemorrhagic stroke events, and related estimates
were generally negative but not statistically significant and did not exhibit a dose-response
(Table 3) (41). Similarly, Noda et al. found non-significant, inconsistent associations for two
hemorrhagic stroke subtypes (Table 1) (33).
Analytical Issues
Several analytical issues emerged in the reviewed studies: (1) whether results were adjusted
for clinical CVD risk factors such as BMI, blood pressure, or lipid profiles, (2) the method
used to control for other PA, and (3) strategies to control for pre-existing illness.
Adjustment variables—Studies generally adjusted for a series of clinical CVD risk factors
and other PA simultaneously or for neither set of variables, precluding distinction of the
impacts of adjustment for specific risk factors (e.g., BMI or blood pressure) or other PA on
study results. Adjustment for clinical CVD risk factors and other PA generally attenuated but
did not eliminate the association between walking and CVD. For example, in the Nurses Health
Study, a 54% reduction in fatal and non-fatal CHD events associated with accumulation of ≥10
versus <5 MET-hours/week of walking was attenuated to 35% but remained significant after
adjusting for clinical CVD risk factors (Table 3) (43). In other studies, adjustment for clinical
CVD risk factors and/or other PA resulted in negligible changes in estimated associations. For
example, reduction in CHD risk for men in the Honolulu Heart Program reporting >1.5 versus
<0.25 miles was 55% and 57% before and after adjusting for clinical CVD risk factors,
respectively, after converting to preventive effects of walking (Table 2) (35).
Strategies to control for other PA—Other PA was generally defined as VPA or other
measures such as sports participation (33) or exercise frequency (37). Studies excluding
subjects with no VPA (32,43,45,48) yielded similar associations to covariate adjustment for
other PA. Hu et al. found similar walking-total stroke associations after controlling (versus
excluding) for VPA (HR=0.66 and 0.64, respectively, for the highest versus lowest walking
levels) (Table 3) (41). In contrast, Lemaitre et al. found similar associations (OR= 0.34)
between nonfatal MI and energy expenditure from walking after excluding subjects with no
strenuous PA and an exceptionally strong association after excluding subjects with no PA other
than walking (OR=0.11) (Table 5) (48).
Control for pre-existing illness—Studies that addressed pre-existing conditions used
various strategies: (a) control for self-reported health status in multivariate analysis, (b)
exclusion of individuals who were physically incapable, had poor health or did not engage in
any PA, and (c) exclusion of events that occurred early in follow-up (Table 6). No pattern in
the magnitude or direction of walking-CVD associations emerged with respect to the method
used to control for pre-existing illness.
DISCUSSION
Observational studies suggest incremental reductions in CVD risk with higher levels of
walking, particularly with faster pace. Incomplete attenuation of associations after adjusting
for clinical CVD risk factors or other PA suggests that walking may reduce CVD incidence
through improvements in CVD risk factors such as BMI but may also have independent effects.
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This point is particularly important relative to recommendations to increase MPA (3), with
walking as a prime candidate given its popularity, relative ease, and accessibility.
Dose-response: volume and intensity
Volume—In general, CVD risk decreased incrementally with higher walking duration,
distance, and energy expenditure, providing support for causal effects of walking on CVD. In
some studies, reductions in CVD remained constant after additional increases in walking. This
pattern could reflect a threshold effect (which contradicts research for total PA (51)), chance
findings, or bias due to physical functioning, discussed in greater detail in subsequent sections.
The dose-response curves in Figure 1 clearly show the general nature of the relationship,
although they should be used only to aid interpretation because their shape may have been
influenced by assumptions regarding the upper limit of the highest walking level, or in
differences in walking levels across populations.
MPA recommendations of 30 minutes per day, five days per week (3) translate into 2.5 hours
and 7.5 MET-hr of walking per week (assuming a 3 MET walking pace). Overall, walking
levels significantly associated with reduced CVD risk are consistent with these
recommendations.
Intensity—Incremental decreases in CVD risk were observed for walking pace increasing
from <2 to >4 mph, even after accounting for distance or duration walked. These associations
may reflect reductions in CVD risk expected with increasing intensity. Alternatively, walking
pace may reflect lower functional status (52) or may be a weak indicator of cardiovascular
fitness (53).
Stronger associations between CVD and walking pace than duration or distance could result
from more accurate reporting of walking pace (32). Self-reported walking measures have only
fair reliability (54), presumably because walking bouts are not always planned or tracked, an
issue less relevant to pace.
Study design, outcomes, and biases
Overall findings should be interpreted in the context of several methodological issues:
Study design—In general, walking-CVD associations were stronger in case-control than
cohort studies, which could reflect differences in causal mechanisms or different sources of
bias. Acute conditions (e.g., stroke, MI) examined in case-control studies could be particularly
related to walking, perhaps because, as theorized by Noda at al., MPA such as walking may
reduce insulin resistance, which is more related to ischemic stroke than CHD (33). Potential
causal mechanisms are supported by stronger associations for ischemic stroke than CHD or
total CVD in cohort studies.
Recall bias is a concern in any case-control study, but especially for proxy responses, which
are necessary for study outcomes with high fatality (49). Additionally, self-selection due to
subclinical disease or pre-existing conditions that prohibit or limit walking but increase CVD
risk for reasons other than walking is problematic in any observational study but particularly
for case-control studies. First, exposure, outcome, and measures of self-reported health are
measured simultaneously, although bias can arise in prospective studies if these conditions
were present at baseline. Second, exclusion of events early in follow-up, perhaps the most
objective method to control for pre-existing conditions, is not possible.
The reviewed cohort and case-control studies provide evidence for bias due to pre-existing
conditions. While exclusion of early cases did not affect estimates in many studies, Gregg et
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al. found substantial attenuation of associations between total PA and CVD mortality after
exclusion of early cases (44). Researchers often performed such secondary analyses for total
PA but not walking, but the bias could be greater for walking because functional status may
more strongly influence walking than total PA. Indeed, Lemaitre et al. found substantially
stronger effects of walking on MI after excluding those with no PA other than walking versus
no strenuous PA (48). Reporting no strenuous PA could reflect differences in lifestyle choices,
while reporting no PA other than walking may reflect functional limitation.
Additionally, walking as little as 9 minutes or 0.4 miles/day, or expending any amount of energy
from walking (>0 MET-hr) were found to significantly reduce CVD risk. These walking levels
translate into much less PA than current recommendations and possibly reflect bias rather than
causal effects. However, studies generally showed a negative dose-response with increasing
walking level, suggesting that these associations can be attributed to more than functional
ability to walk.
Adjustment variables—Adjustment for clinical CVD risk factors and other types of PA
generally attenuated the observed association. PA improves blood pressure (55) and lipid
profiles (56), and reduces obesity (57) and diabetes (58), so walking may prevent CVD through
one or more of these pathways. Additionally, other types of PA may be important confounders
of the walking-CVD association because those who walk may also engage in other forms of
PA (59) that influence CVD risk (7).
Longitudinal associations not fully mediated by clinical CVD risk factors or confounded by
other PA could be explained by residual confounding or bias. Alternatively, walking may
provide unique benefits not conferred by other types of PA, such as walking enjoyment which
may reduce stress or elevate positive psychological factors (60).
Given the accessibility of walking and high prevalence of inactivity (61) and obesity (62) in
the U.S. adult population, less active and obese individuals are promising target populations.
For example, studies that restrict analysis to those not reporting VPA (32,42,43,45) are
particularly relevant to public health recommendations. Obesity is an independent CVD risk
factor, and recent studies suggest that PA (63) and walking (64) improves CVD risk in
overweight and obese individuals. While the reviewed studies do not investigate the walking-
CVD association in obese subgroups, there is a clear need for more research on the differential
effects of walking on CVD by obesity status.
Demographic Subgroups
We observed no evidence that walking-CVD association varied by gender or age. Gender-
stratified results were inconsistent: Noda et al. reported stronger effects in men for CHD but
stronger effects in women for total CVD and stroke (33), and Folsom reported stronger effects
in women than men for CHD (31). Study populations typically captured middle to older age
groups, but some focused on adults over 60 years (34–36,44).
Complexities of estimating health effects of walking in observational studies: Limitations
and future research
While observational studies enable ascertainment of CVD end points in large samples rather
than clinical CVD risk factors in relatively small samples typically examined in experimental
studies, they have important limitations. Those most relevant to estimating the causal effects
of walking on CVD risk and corresponding opportunities for future research include:
Residual confounding—Many studies adjusted for other PA and pre-existing conditions,
but future studies should consider collecting additional data needed to better address these key
Boone-Heinonen et al. Page 8













sources of potential residual confounding. Diet is another major CVD determinant (65), but
few studies adjusted for diet and none assessed the joint effect of diet and walking on CVD
risk, which would strengthen evidence regarding walking and CVD and inform comprehensive
prevention strategies.
Analytical considerations—Negative walking-CVD associations may result from
improvement in intermediate risk factors or through confounding or interaction with other PA.
Therefore, adjustment of specific clinical CVD risk factors and other PA in separate models
may clarify the contribution of each. However, these factors did not explain the relationship
entirely, so future studies could investigate alternative mechanisms such as stress reduction by
which walking may reduce CVD risk.
Importantly, estimation of walking-CVD associations in obese or otherwise sedentary
populations would inform public health recommendations and targeting of these high risk
groups. However, such subgroup analysis should be performed with caution: BMI or other PA
may influence current walking, but may also be influenced by past walking through weight
loss or reduced barriers to other PA. Conditioning on BMI or other PA can induce selection
bias (66), warranting consideration of potential bias and appropriate analytical methods in
future studies.
While standardization of walking categories obtained from existing assessment instruments
may be difficult, it would help to further evaluate PA recommendations. Estimates of the effects
of walking (versus not walking) could also facilitate comparison across studies and is consistent
with the conception of walking as prevention.
Measurement—All studies used self-reported PA, typically at one time point, with minimal
validation against objective measures. While many of the reviewed studies began before
objective PA measures were available for epidemiologic research, studies initiated more
recently could complement self-reported walking behavior with pedometer or accelerometer
data to obtain potentially more precise estimates of walking duration and intensity. This could
enhance comparability across age or physical abilities by reducing heterogeneity of self-
reported walking due to, for example, slower pace and shorter duration among those of older
age, poor fitness, or diminished physical abilities (34). Self-reported walking remains
important because it can capture habitual PA patterns, and, with the exception of emergent
measurement methods (e.g., (67)), objective measures do not distinguish between types of PA.
Additionally, walking volume measures and pace are related: for example, faster pace implies
longer distance walked and higher energy expenditure per given duration. Collection of
walking intensity (pace), frequency, and duration may help to disentangle their independent
effects and reduce heterogeneity in walking measures. Assessing dose-response of walking
frequency (not addressed in studies reviewed), in combination with intensity and duration could
also help to refine walking recommendations. Finally, ascertainment of PA and walking
behavior at multiple time points would help to capture short-term changes and examine the
benefits of walking throughout the life cycle.
Walking as secondary measure—With some exceptions (33–37,42,43), walking was
examined as a secondary measure in studies primarily designed to examine overall PA, which
may have exacerbated study biases. First, reliability and validity was often assessed for the
total PA measure but not its components (e.g., walking); this aspect of the review was not
comprehensive, however, so walking measures may have been assessed but not reported, or
studied after publication of the reviewed studies. Second, total PA analyses were often more
thorough than walking analyses. For example, several studies controlled for pre-existing
conditions by excluding cases that occurred early in follow-up (39–41,43,44) or application of
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propensity score methods (44,45) for total PA but not walking. Finally, findings for secondary
exposures may be particularly susceptible to publication bias. Studies that assess walking as a
primary exposure may be more likely to ensure that walking measures are reliable and valid,
perform more thorough analyses, and report null findings.
Strengths and Limitations of the Systematic Review
While our search may have excluded relevant studies, several factors minimize this possibility.
Our start date of 1990 is conservative because it preceded major research interest in walking
initiated by PA recommendations published in 1995 (2,15), and major studies that examined
walking prior to 1990 have been updated (e.g., (39)). Further, a recently published meta-
analysis confirms this time frame (11). We also conducted parallel searches in two extensive
health and medical research databases, which was supplemented by a manual search protocol.
By including only peer reviewed articles, our review is vulnerable to publication bias. However,
this bias is balanced by quality assurance provided by the peer review system, a priority in this
review which focused on methodological differences and limitations. Overall, our literature
search criteria and procedures were carefully developed and well-defined, resulting in a
systematic review that is transparent and replicable.
Summary and Implications
Existing literature suggests that walking reduces CVD risk in men and women across a broad
age spectrum, and that walking for longer duration or distance confers additional protection
against CVD. There is consistent evidence that CVD risk declines with increasing walking
pace, and, based on research assessing overall PA (7), probably continues to decline into
vigorous intensities. The favorable relationship observed among adults who do not report VPA
suggest that walking is a promising CVD prevention strategy in a largely sedentary population.
Given its accessibility, walking may help to reduce perceived barriers to PA such as access to
exercise facilities (68) and promote higher levels of MPA or addition of VPA.
This review assessed walking and CVD, but by acting on intermediate risk factors such as
obesity and insulin sensitivity, walking is also an important risk factor for numerous other
health outcomes. Conclusions about general health benefits of walking require assessment of
the relationship between walking and other conditions such as obesity and diabetes mellitus
type II.
CVD and other chronic diseases are major contributors to global morbidity and mortality. It is
essential to improve our understanding of activities such as walking that reduce CVD and
chronic disease risk and are relevant given the demographic shift toward an older, obese, and
sedentary population.
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Figure 1. Dose-response relationships between walking MET-hours/week and risk of specific CVD
outcomes
M, Male; F, Female; IS, ischemic stroke; HS, hemorrhagic stroke; IH, intraparenchymal
hemorrhage; SH, subarachnoid hemorrhage
Walking measures were converted to MET-hours/week assuming 3-MET intensity on a firm
surface, for a 150 pound person. Frequency measures binary and were not included in the graph.
Plotted points are equal to the midpoint of each category. In most studies, an upper bound was
not reported for the highest walking category; in these cases, the upper bound was assigned
twice the value of the lower bound. Associations for outcomes other then the three presented
(e.g., “other CVD”) and for total stroke (if stroke subtypes were reported) were excluded from
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these graphs. Case-control studies were excluded due to non-comparability of estimates to
cohort studies.
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Table 6
Methods used to control for pre-existing illness in assessment of the association between walking and CVD
Study Method
GISSI-2 (Italy) (D’Avanzo et al, 1993 (50)) Exclude subjects with history of Ischemic
Heart Disease
Whitehall Study (Davey Smith, 2000 (46)) Excluded men with disease at entry
No change to results after excluding deaths
in the first 5 and 10 years of follow-up
Atherosclerosis in Communities Study (ARIC) (Evenson et al, 1999 (30)) -NA-
Atherosclerosis in Communities Study (ARIC) (Folsom 1997 (31)) -NA-
Study of Osteoporotic Fractures (Gregg et al, 2003 (44)) Exclude subjects unable to walk without
assistance
Adjust for self rated health
No change to results after excluding first 2
years of follow-up
Honolulu Heart Program (Hakim et al, 1998 (36)) Exclude subjects who are physically
incapable
No change to results after excluding deaths
within first year of follow-up
Honolulu Heart Program (Hakim et al, 1999 (35)) Exclude subjects incapable of ≥1 hour
activity
Adjust for physical function score
No change to results after excluding those
who reported no walking
Nurses Health Study (Hu et al, 2000 (41)) -NA-
Group Health Cooperative of Puget Sound (LaCroix et al, 1996 (34)) -Exclude subjects with self-reported heart
trouble at baseline, CVD-related
prescription drugs or hospitalization in
past 12 months
-Adjust for self-reported functional status,
health status, chronic disease score
-Secondary analysis found effect in those
with and without functional limitations
Women's Health Study (Lee et al, 2001 (32)) -NA-
Harvard Alumni Health Study (Lee et al, 1998 (38)) -NA-
Group Health Cooperative of Puget Sound (GHC) (Lemaitre et al, 1995 (48)) Adjust for symptoms in month priorto
index date
King County, WA Residents (Lemurtre et al, 1999 (49)) Adjust for self-reported health status
Exclude subjects with history of heart
disease, or reported poor health in the prior
year
Nurses Health Study (Manson et al, 1999 (43)) No change in results after excluding
subjects unable to walk
Women's Health Initiative Observational Study (Manson et al, 2002 (42)) WHI Study excluded those who were non-
ambulatory
Total CVD Outcome: No change in results
after excluding events occurring in first
year of follow-up, or adjusting for
functional status, mental and emotional
health
Japan Collaborative Cohort Study for Evaluation of Cancer Risk (Noda et al, 2005 (33)) Used second-lowest walking category as
referent group
No change to results after excluding deaths
within first 2 years of follow-up
Harvard Alumni Study (Sesso et al, 2000 (39)) -NA-
College Alumni Health Study (Sesso et al, 1999 (40)) -NA-













Boone-Heinonen et al. Page 29
Study Method
West Birmingham, UK (Shinton et al, 1993 (47)) Exclude subjects reporting poor health, or
with history of myocardial ischemia or
peripheral vascular disease
Residents of Rancho Bemardo, CA (Smith et al, 2007 (37)) Adjust for history of CHD
Health Professionals Follow-up Study (Tanasescu et al, 2002 (45)) Exclude subjects reporting difficulty
walking or climbing stairs
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